UnitedHealth Group Incorporated (NYSE:UNH) is Ferguson Wellman Capital Management Inc.’s 9th Largest Position

Ferguson Wellman Capital Management Inc. lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 24.1% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 174,112 shares of the healthcare conglomerate’s stock after buying an additional 33,838 shares during the period. UnitedHealth Group comprises 2.1% of Ferguson Wellman Capital Management Inc.’s holdings, making the stock its 9th largest holding. Ferguson Wellman Capital Management Inc.’s holdings in UnitedHealth Group were worth $101,800,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in UNH. Kathleen S. Wright Associates Inc. bought a new position in UnitedHealth Group during the third quarter valued at $27,000. Global Wealth Strategies & Associates grew its holdings in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares during the last quarter. Macroview Investment Management LLC lifted its stake in UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares during the last quarter. West Financial Advisors LLC bought a new position in shares of UnitedHealth Group during the third quarter valued at approximately $32,000. Finally, Delos Wealth Advisors LLC lifted its stake in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 53 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.6 %

UnitedHealth Group stock opened at $569.61 on Friday. The business has a fifty day moving average price of $584.42 and a 200-day moving average price of $534.15. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $608.63. The stock has a market capitalization of $524.26 billion, a price-to-earnings ratio of 34.82, a PEG ratio of 1.69 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same period last year, the firm posted $6.56 EPS. UnitedHealth Group’s revenue was up 9.2% on a year-over-year basis. Equities research analysts forecast that UnitedHealth Group Incorporated will post 27.68 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.47%. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on UNH. Truist Financial reiterated a “buy” rating and issued a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday. Stephens decreased their price objective on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a report on Wednesday. Morgan Stanley decreased their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday. Argus lifted their target price on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Finally, HSBC lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday. Three investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $615.58.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.